Network pharmacology analysis revealed the mechanism and active compounds of jiao tai wan in the treatment of type 2 diabetes mellitus via SRC/PI3K/AKT signaling
JTW may alleviate glucose, insulin resistance, and lipid metabolism disorders by the SRC/PI3K/AKT signaling pathway, that provide a novel view of potential active compounds and essential targets in treating T2DM.
Authors
- Shijian Quan (ORCID: https://orcid.org/0000-0002-9853-5630)
- Xinyan Shi (ORCID: https://orcid.org/0000-0003-4671-3981)
- Cunsi Ye (ORCID: https://orcid.org/0000-0001-6900-7217)
- Wenbo Lei (ORCID: https://orcid.org/0000-0002-7523-355X)
- Yumeng Li (ORCID: https://orcid.org/0000-0002-9986-5201)
- Wei Yang (ORCID: https://orcid.org/0000-0003-0198-1632)
- Xiaopeng Lan (ORCID: https://orcid.org/0000-0002-3603-1568)
- Shuangquan Liu (ORCID: https://orcid.org/0000-0002-2690-2665)
- L He
- Jiayin Shi
Institutions
- Guangzhou University of Chinese Medicine (CN)
- University of South China (CN)
Publication Details
- Journal
- Journal of Ethnopharmacology
- Published
- 2024-10-05
- DOI
- https://doi.org/10.1016/j.jep.2024.118898
- Citations
- 24
- Primary Topic
- Chromatography in Natural Products
- Type
- article
- Field-Weighted Citation Impact
- 5.66